Nyxoah (ENXTBR:NYXH) Price Target Reduced by 17.36% to 10.07

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Dec 07 2025

0mins

Source: NASDAQ.COM

Price Target Revision: The average one-year price target for Nyxoah has been revised down to €10.07 per share, a decrease of 17.36% from the previous estimate of €12.19, but still represents a potential increase of 135.34% from the current closing price of €4.28.
Fund Sentiment: There are currently 50 funds reporting positions in Nyxoah, a slight decrease of 1.96% from the previous quarter, with the average portfolio weight dedicated to Nyxoah increasing by 39.55%.
Shareholder Activity: Vestal Point Capital reduced its holdings by 26.60%, while FCPGX increased its allocation by 10.01%. Other funds like BlackRock Health Sciences Trust II significantly decreased their shares by 110.87%.
Fintel Overview: Fintel provides comprehensive investing research tools, including fundamentals, analyst reports, and fund sentiment, aimed at individual investors and small hedge funds.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free